Navigation Links
Genstar Capital Completes ERT Acquisition In A Take-Private Transaction
Date:7/3/2012

PHILADELPHIA, July 3, 2012 /PRNewswire/ -- ERT (Nasdaq: ERT), a global technology-driven provider of health outcomes services to biopharmaceutical sponsors and contract research organizations (CROs), announced today that Genstar Capital, LLC, has completed its acquisition of the company in a take-private transaction valued at approximately $400 million.

Dr. Jeffrey Litwin, who will continue to lead ERT as CEO, said, "As a private company we will continue to serve our customers and enhance our suite of products. We have been able to grow our company into a global leader, and, with Genstar's partnership, we will look for creative new ways to grow our business organically and identify new investment opportunities as part of our continued development."

"ERT is already the global leader in its sector yet we believe the company can benefit from our expertise in the pharmaceuticals industry to create positive change that will drive operations at an increased pace," said Robert Weltman, Managing Director of Genstar.  "This is a sector we know well, and the added strength of our operating partners and strategic advisory board will help build ERT into a stronger independent platform company. We are eager to work with ERT's management team to position this compelling company for sustained growth by implementing growth oriented strategic initiatives, including establishing more strategic relationships with customers and identifying new expansion opportunities."

For further information on ERT and its technology and services, please email info@ert.com, call +1 215 972 0420 or visit www.ert.com

About ERT

ERT (www.ert.com) is a global technology-driven provider of health outcomes research services supporting biopharmaceutical sponsors and Contract Resea
'/>"/>

SOURCE ERT
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. PLC Systems Secures Additional Financing For US Clinical Trials And General Working Capital
2. HeartWare Completes Enrollment In 450-Patient Pivotal Destination Therapy Clinical Trial
3. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
4. NuMe Health Completes $1.5 Million Series A Financing To Advance Its First Cobiotic™ Aimed At Helping Prediabetics Maintain Healthy Blood Glucose Levels
5. CryoLife Completes Acquisition of Hemosphere
6. Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals
7. Savara Pharmaceuticals Completes Phase I Clinical Study of AeroVanc in Cystic Fibrosis Patients
8. Jazz Pharmaceuticals Completes EUSA Pharma Acquisition
9. Amgen Completes Acquisition of Mustafa Nevzat Pharmaceuticals
10. Ablative Solutions Completes $5.3M Series A Financing
11. Quantum OPS Completes $1.05M In Series A Financing To Advance Surgical Devices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014  Hill-Rom Holdings, Inc. ... to a management presentation at the Morgan Stanley Global ... EDT. You are invited to listen to ... http://ir.hill-rom.com/events.cfm or access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP ... available one hour after conclusion of the live event ...
(Date:8/27/2014)... 2014 Sihuan Pharmaceutical Holdings Group Ltd. ... leading pharmaceutical company with the largest cardio-cerebral vascular ... prescription drug market, today announced the unaudited ... (collectively the "Group") for the six months ended ... HighlightsFor the Six months ended 30 JuneKey Income ...
(Date:8/27/2014)... , Aug. 27, 2014  CVS Caremark (NYSE: ... into a new clinical affiliation with MedStar Health, a ... Maryland and the Washington, ... high-quality, affordable health care services for patients. Through this ... access to clinical support, medication counseling, chronic disease monitoring ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7CVS Caremark Announces New Clinical Affiliation with MedStar Health 2CVS Caremark Announces New Clinical Affiliation with MedStar Health 3
... 2010 Curemark LLC , a drug research and ... today that it has been awarded a grant by the ... Program to advance the development of its lead product CM-AT ... at 18 sites around the US. The QTDP ...
... VALLEY, Calif., Nov. 2, 2010 Spectros Corporation ... with the T-Stat VLS Tissue Oximeter at the ... newly released data was presented during poster sessions ... Circulation: Pharmacology/Physiology", held at the American Society of ...
Cached Medicine Technology:Curemark Awarded Qualifying Therapeutic Discovery Project (QTDP) Grant 2Spectros Presents New Clinical Studies Using T-Stat VLS Tissue Oximeter at Anesthesiology 2010 2
(Date:8/27/2014)... August 27, 2014 Taking its popular obstacle ... Steele Creek YMCA will host its largest crowd at ... Saturday, September 13 at YMCA Camp Thunderbird . ... divisions: adult, youth and teams. Within each division, runners ... their physical limit - for a worthy cause. All ...
(Date:8/27/2014)... 27, 2014 Reviewing the prices that ... be easier for the public when using the Quotes ... promoted in all 50 states in the U.S. are ... different insurers that are generating the rates information from ... adults to use the programmed system without charge. Because ...
(Date:8/27/2014)... Shawna's new book, released in ebook ... Digging, which a brand-new technique she created. Seed digging ... to bring permanent healing quickly. , According to Burns, ... disorders cured on a daily basis. It teaches people ... find incredible inner peace with only a few simple ...
(Date:8/27/2014)... The New York Mobility Club (sponsored ... events about “ Sexuality & Intimacy ” for people ... and entertaining discussions are for mature audiences only. September ... Avenue, Mamaroneck, NY) and October 7 from 6-8 pm ... , The New York Mobility Club is a local ...
(Date:8/27/2014)... 2014 Top 10 Best SEO Hosting, a ... hosting suppliers and announced iPage, Bluehost and GoDaddy are the ... Australia and Europe to buy useful hosting (including VPS and ... suppliers, iPage has been serving hosting small business ... has grown into a leader in the hosting industry for ...
Breaking Medicine News(10 mins):Health News:C2 Survival Racers Go to Extremes to Provide Kids with YMCA Programs 2Health News:Home Insurance Prices for All 50 States Now Supplied at Consumer Insurance Portal Online 2Health News:Shawna Burns, Counselor, Releases Debut Book, "Seed Digging," to Improve Lives of Children and Adults with Addictions and Mental Health Disorders 2Health News:Bussani Mobility Sponsors New York Mobility Club Meetings September 9 & October 7 for People with Disabilities, Sexuality & Intimacy Discussed by Advocate Liz Treston 2Health News:Well-known SEO Hosts Review Site Top10BestSEOHosting.com Recommends iPage, Bluehost and GoDaddy To Webmasters 2
... BIRMINGHAM, Ala., Sept. 8 BioCryst Pharmaceuticals, Inc. (Nasdaq: ... summaries at two upcoming investor conferences. , , ... is scheduled to present a corporate summary at the Rodman & ... 2:25 p.m. Eastern Time. The conference will be held September 9-11, ...
... ... Use in Epocrates Survey , ... San Mateo, CA (PRWEB) September 8, 2009 -- Epocrates, Inc., a leading provider ... role of technology use in hospitals and clinics across the nation. , , ,The majority ...
... , , , ... on its recent analysis of the dairy animal nutrition market, ... business of Church & Dwight Company Incorporated, with the 2009 ... the Year Award. It acknowledges the company,s excellence in developing ...
... , , LONDON, Sept. ... Ingredients Excellence in Financial & Risk Management Award is presented ... the first and only EU-and FDA-approved omega-3 derived prescription drug. ... the USA, the product is a prescribed adjunct to diet ...
... ... in using electronic cigarette, the private research group has recently completed survey of 10,000 ... ... is a battery-powered device that provides inhaled doses of nicotine by delivering a vaporized ...
... ... testimonial for ColorAlchemy by licensed Marriage and Family Therapist and Clinical Hypnotherapist David Swindoll now ... ... Therapist and Clinical Hypnotherapist for over thirty years. He has found the use of ColorAlchemy ...
Cached Medicine News:Health News:BioCryst Executives to Present at Two Investor Conferences 2Health News:Nurses Facing National Shortage Turn to Mobile Technology to Support Patient Care 2Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 2Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 3Health News:Frost & Sullivan Cites Arm & Hammer for Excellence in the Dairy Animal Nutrition and Management Market 4Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 2Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 3Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 4Health News:Frost & Sullivan Global Heart Health Ingredients Excellence in Financial & Risk Management Award Conferred on Pronova BioPharma 5Health News:Electronic Cigarette Known as ecig Helps You Quit Smoking 2Health News:Electronic Cigarette Known as ecig Helps You Quit Smoking 3Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 2Health News:Licensed Marriage and Family Therapist and Clinical Hypnotherapist Provides Powerful Video Testimony for ColorAlchemy and Color Therapy 3
... for urinary albumin that allows for early ... CLIA Waived test has a sensitivity of ... gives accurate results in only 3 minutes ... hours. Since early detection is one key ...
... Drug Screen Tests are available in 14 ... (Ecstasy). Designed using Microgenics Antibody Technology, the ... point of care immunoassay targeted to detect ... MDA and MDEA but no cross-reactivity to ...
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... Screen Tests are available in 14 configurations ... Designed using Microgenics Antibody Technology, the SureStep™ ... of care immunoassay targeted to detect MDMA ... and MDEA but no cross-reactivity to any ...
Medicine Products: